/ /

  • linkedin
  • Increase Font
  • Sharebar

    FLACS offers enhanced surgical precision, patient safety, reliability

    Comfortability of patient is critical element for successful premium cataract surgery


    What the data say

    A recent study I conducted included the collection of data on a range of metrics from patients undergoing cataract surgery with a femtosecond laser (Catalys, Johnson & Johnson Vision/AMO). Additionally, patients were surveyed to evaluate satisfaction with their femtosecond laser assisted treatment.

    Subjects were in good health with visual potential of 20/25 or better and a pre-operative corneal astigmatism of 1.5 D or less. The density of cataract was across all spectrum 2 to 4 + nuclear sclerosis (NS). IOLs implanted included monofocal, toric, and multifocal lenses based on the patient’s desired visual goals and the surgeon’s standard of care.

     

    Data showed a mean cortex removal time of 86.3 seconds and a mean effective phaco time of 21.4 seconds. Overall, the average phaco power used was only 6.2%. Importantly, endothelial cell count was largely unchanged. At baseline the mean count was 2705.9/mm2 compared with a mean of 2711.1/mm2 at 30 to 60 days postoperative.

    As Figure 1 shows, cortex removal was easy, there were no moderate or severe sub-conjunctival hemorrhages, no incomplete capsulotomies, no vision loss, and the majority of patients perceived no pressure during the time the laser was docked on the eye.

    When this data was compared with other femtosecond laser platforms, the overall data was comparable. The laser demonstrated little or no endothelial cell loss and had the best overall patient comfort. A comfortable patient is key for building a premium cataract surgery practice.

    The capsulotomy perfected

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results